tiprankstipranks
Trending News
More News >
Helix BioPharma (TSE:HBP)
TSX:HBP
Canadian Market

Helix BioPharma (HBP) Income Statement

Compare
30 Followers

Helix BioPharma Income Statement

Last quarter (Q1 2026), Helix BioPharma's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Helix BioPharma's net income was C$-1.01M. See Helix BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -10.00KC$ -14.00KC$ -13.00KC$ -12.00KC$ -173.00K
Operating Expenses
C$ 5.42MC$ 9.36MC$ 6.33MC$ 6.04MC$ 9.13M
Depreciation and Amortization
C$ 10.00KC$ 14.00KC$ 13.00KC$ 12.00KC$ 173.00K
EBITDA
C$ -5.21MC$ -9.38MC$ -6.31MC$ -6.03MC$ -9.46M
Operating Income
C$ -5.42MC$ -9.37MC$ -6.28MC$ -6.54MC$ -9.61M
Other Income/Expenses
C$ 192.00KC$ -25.00KC$ 36.00KC$ -523.00KC$ -443.00K
Pretax Income
C$ -5.23MC$ -9.40MC$ -6.29MC$ -6.56MC$ -9.57M
Net Income
C$ -5.21MC$ -9.26MC$ -6.29MC$ -6.08MC$ -7.91M
Per Share Metrics
Basic EPS
C$ -0.09C$ -0.21C$ -0.16C$ -0.20C$ -0.29
Diluted EPS
C$ -0.09C$ -0.21C$ -0.16C$ -0.20C$ -0.29
Weighted Average Shares Outstanding
55.74M 44.49M 38.65M 29.90M 27.58M
Weighted Average Shares Outstanding (Diluted)
55.74M 44.49M 38.65M 29.90M 27.58M
Currency in CAD

Helix BioPharma Earnings and Revenue History